Aprotinin restores the adhesive capacity of dysfunctional platelets

作者: John F. Bradfield , Arthur P. Bode

DOI: 10.1016/S0049-3848(03)00182-8

关键词:

摘要: The post-operative coagulopathy associated with cardiopulmonary bypass (CPB) is known to be predominantly related platelet dysfunction. use of the serine protease inhibitor aprotinin dramatically reduces CPB hemorrhage and thought act primarily through inhibition plasmin without directly influencing platelets. Our data indicate that there a direct effect on adhesion, which has not been previously reported. We found when was added blood samples poorly adhesive platelets, adhesion significantly increased as measured by percent coverage denuded arterial segments in Baumgartner perfusion chamber. In preliminary experiments using expired concentrates or fresh whole blood, addition induced positive increase 22+/-7.5 14+/-6.2 percentage point respectively. A simulated model recirculated unit anticoagulated for 2 h used (n=14) induce defect similar seen clinical CPB. At initiation recirculation, 55+/-9.5% but dropped 13+6.5% after post-recirculation significant restoration back 38+/-11% coverage. When epsilon amino-caproic acid soybean trypsin post recirculation samples, no scores. To compare these findings surgical CPB, we collected one sample at beginning two end from each seven open-heart patients. Aprotinin post-CPB samples. Platelet onset only 39+/-11% this patient group 7+/-7% end. Similar model, restored 29+/-11%. These results suggest some action other than its antiplasmin effect, general can promoted aprotinin.

参考文章(23)
Alexander Wahba, Gregor Black, Mario Koksch, Gregor Rothe, Jürgen Preuner, Gred Schmitz, Dietrich E Bimbaum, Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass Thrombosis and Haemostasis. ,vol. 75, pp. 844- 848 ,(1996) , 10.1055/S-0038-1650377
RC Woodman, LA Harker, Bleeding Complications Associated With Cardiopulmonary Bypass Blood. ,vol. 76, pp. 1680- 1697 ,(1990) , 10.1182/BLOOD.V76.9.1680.1680
AS Kestin, CR Valeri, SF Khuri, J Loscalzo, PA Ellis, H MacGregor, V Birjiniuk, H Ouimet, B Pasche, MJ Nelson, The Platelet Function Defect of Cardiopulmonary Bypass. Blood. ,vol. 82, pp. 107- 117 ,(1993) , 10.1182/BLOOD.V82.1.107.BLOODJOURNAL821107
Willem van Oeveren, Marcel P. Harder, Klaas J. Roozendaal, Leon Eijsman, Charles R.H. Wildevuur, Aprotinin protects platelets against the initial effect of cardiopulmonary bypass The Journal of Thoracic and Cardiovascular Surgery. ,vol. 99, pp. 788- 797 ,(1990) , 10.1016/S0022-5223(19)36893-X
John M. Murkin, JoAnn Lux, Nicola A. Shannon, Gerard M. Guiraudon, Alan H. Menkis, F. Neil McKenzie, Richard J. Novick, Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations The Journal of Thoracic and Cardiovascular Surgery. ,vol. 107, pp. 554- 561 ,(1994) , 10.1016/S0022-5223(12)70102-2
M. A. Orchard, C. S. Goodchild, C. R. M. Prentice, J. A. Davies, S. E. Benoit, L. J. Creighton-Kemsford, P. J. Gaffney, A. D. Michelson, Aprotinin reduces cardiopulmonary bypass‐induced blood loss and inhibits fibrinolysis without influencing platelets British Journal of Haematology. ,vol. 85, pp. 533- 541 ,(2008) , 10.1111/J.1365-2141.1993.TB03344.X
Jacob Lavee, Zvi Raviv, Aram Smolinsky, Naphtali Savion, David Varon, Daniel A. Goor, Rephael Mohr, Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. The Annals of Thoracic Surgery. ,vol. 55, pp. 114- 119 ,(1993) , 10.1016/0003-4975(93)90484-Y
P KALLIS, J TOOZE, S TALBOT, D COWANS, D BEVAN, T TREASURE, Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial. European Journal of Cardio-Thoracic Surgery. ,vol. 8, pp. 315- 323 ,(1994) , 10.1016/S1010-7940(05)80092-2
Robert W. Colman, Hemostatic complications of cardiopulmonary bypass American Journal of Hematology. ,vol. 48, pp. 267- 272 ,(1995) , 10.1002/AJH.2830480412